EnBio Holdings, Inc. (6092) AI Stock Analysis

• Market Cap: ¥4.76B
• Dividend Yield: 1.41%
• Average Volume (3M): 11.93K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.60
• Revenue Growth: 29.35%
• EPS Growth: 205.12%
• Country: JP
• Employees: 104
• Sector: Industrials
• Sector Strength: 90
• Industry: Specialty Business Services
• EPS (TTM): -13.91
• Shares Outstanding: 8,175,200
• 10 Day Avg. Volume: 6,110
• 30 Day Avg. Volume: 11,926
• PEG Ratio: 0.32
• Price to Book (P/B): 0.53
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

EnBio Holdings' stock is driven by strong financial performance and attractive valuation metrics, with a solid revenue growth trajectory and reasonable profitability margins. While the technical analysis presents mixed signals, the low P/E ratio suggests undervaluation, making it an appealing investment option despite challenges in cash flow stability. The absence of recent earnings call data and corporate events does not impact the current analysis.

EnBio Holdings, Inc. Business Overview & Revenue Model

Company Description

EnBio Holdings, Inc. (6092) is a Japan-based company primarily engaged in the environmental business sector. The company focuses on providing a range of environmental solutions, including soil and groundwater decontamination services. EnBio Holdings leverages advanced technologies to address environmental challenges, contributing to sustainability and ecological preservation.

How the Company Makes Money

EnBio Holdings, Inc. generates revenue primarily through its environmental service offerings, particularly in soil and groundwater remediation. The company charges fees for its specialized decontamination services, which are essential for construction projects, industrial sites, and areas requiring environmental rehabilitation. Furthermore, EnBio Holdings may form strategic partnerships with government bodies and private sector enterprises seeking sustainable environmental solutions, thereby enhancing its revenue streams. The company's earnings are influenced by regulatory requirements, technological advancements, and the growing emphasis on environmental sustainability.

EnBio Holdings, Inc. Financial Statement Overview

Summary

EnBio Holdings demonstrates a strong growth trajectory in revenue and profitability margins, supported by a stable balance sheet with moderate leverage. However, challenges in maintaining consistent cash flow highlight potential areas for improvement. The company's financial health is robust, but careful attention to cash flow management will be crucial for sustaining growth.

Income Statement

EnBio Holdings has shown a strong revenue growth trajectory, with a 12.65% increase from 2023 to TTM. The gross profit margin for TTM is 27.12%, and the net profit margin is 8.62%, indicating healthy profitability. The EBIT margin is 10.97% and the EBITDA margin is 15.00%, which reflect solid operational efficiency. The company has managed to consistently improve its revenue and profit margins over the recent periods, signaling a positive growth trend.

Balance Sheet

EnBio Holdings has a debt-to-equity ratio of 1.12, suggesting a moderate level of leverage. The return on equity for TTM is 10.45%, which is reasonable and indicates effective use of shareholders' equity. The equity ratio of 42.64% reflects a balanced capital structure. The balance sheet shows stability with a strong equity base, though it does carry a significant amount of debt which should be monitored.

Cash Flow

The company has shown fluctuations in cash flow with a decline in free cash flow in the TTM period. The operating cash flow to net income ratio is unavailable for TTM due to missing data, which limits a deeper analysis. Historically, the free cash flow to net income ratio had been positive in previous years, indicating good cash generation in relation to net income. However, recent periods show challenges in maintaining stable cash flows.

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
10.78B	9.58B	8.12B	8.99B	6.84B	7.41B
	Gross Profit
2.92B	2.48B	2.76B	2.43B	1.89B	2.09B
	EBIT
1.18B	815.15M	1.36B	1.23B	617.90M	674.00M
	EBITDA
1.62B	1.62B	1.76B	1.57B	981.00M	1.10B
	Net Income Common Stockholders
929.29M	708.76M	812.06M	654.05M	304.06M	555.00M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.75B	3.60B	2.83B	2.37B	2.02B	2.98B
	Total Assets
6.22B	19.31B	17.35B	16.37B	15.70B	15.03B
	Total Debt
3.34B	8.62B	8.90B	8.58B	9.04B	8.10B
	Net Debt
1.59B	5.02B	6.07B	6.21B	7.02B	5.15B
	Total Liabilities
3.71B	10.72B	10.49B	10.40B	10.38B	10.14B
	Stockholders Equity
2.51B	8.49B	6.79B	5.89B	5.29B	4.89B
Cash Flow		Free Cash Flow
0.00	584.36M	824.13M	1.25B	-1.43B	594.00M
	Operating Cash Flow
0.00	1.66B	1.99B	2.41B	297.16M	951.00M
	Investing Cash Flow
0.00	-1.58B	-1.77B	-1.48B	-2.16B	3.87B
	Financing Cash Flow
0.00	638.92M	240.73M	-534.92M	928.54M	-4.06B

EnBio Holdings, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 584.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6092, the sentiment is Positive. The current price of 584 is above the 20-day moving average (MA) of 575.60, above the 50-day MA of 577.54, and below the 200-day MA of 590.86, indicating a neutral trend. The MACD of 1.89 indicates Negative momentum. The RSI at 54.57 is Neutral, neither overbought nor oversold. The STOCH value of 50.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6092.

EnBio Holdings, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6092	73 Outperform	¥4.76B	10.18		1.41%	29.35%	205.12%
1979	73 Outperform	¥157.47B	14.51	7.46%	2.81%	-1.82%	5.42%
4626	66 Neutral	¥295.30B	26.66		3.69%	13.59%	24.68%
6289	66 Neutral	¥38.97B	24.89		3.12%	-13.72%	13.42%
Sector *	64 Neutral	$4.42B	12.00	5.16%	249.23%	4.01%	-11.70%
4755	46 Neutral	$1.69T	―	-22.97%	―	10.38%	38.09%
6366	35 Underperform	¥81.06B	3.01	186.66%	―	-12.44%	-168.59%

EnBio Holdings, Inc. Corporate Events

EnBio Holdings, Inc. Reports Strong Financial Growth for 2024 Nine-Month Period

EnBio Holdings, Inc. reported consolidated financial results for the nine months ending December 31, 2024, showing a significant increase in net sales by 17.3% and operating profit by 78.7% compared to the previous year. The results indicate a robust financial performance with an improved equity-to-asset ratio, reflecting the company’s strengthened position in the market.